1998
DOI: 10.1038/bjc.1998.450
|View full text |Cite
|
Sign up to set email alerts
|

Serum polysialylated neural cell adhesion molecule in childhood neuroblastoma

Abstract: Summary Neuroblastoma cells express the polysiatylated form of the neural cell adhesion molecule (NCAM), which normally becomes restricted to a few neural tissues after embryogenesis. In this study, we investigated serum levels of polysialylated NCAM in 14 children with different grades and stages of neuroblastoma using an immunoluminescence assay, and compared the results to 269 healthy control subjects. Simultaneousty, the polysialylated NCAM content of the tumours was determined by immunohistochemistry. Ser… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
30
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(32 citation statements)
references
References 15 publications
2
30
0
Order By: Relevance
“…For example, in colon carcinoma, pancreatic cancer, and astrocytoma, NCAM expression is markedly down-regulated, and the loss of NCAM correlates with poor prognosis (8 -11). In contrast, in neuroblastoma and certain neuroendocrine tumors, cancer progression correlates with increased NCAM expression and extensive polysialylation (12)(13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%
“…For example, in colon carcinoma, pancreatic cancer, and astrocytoma, NCAM expression is markedly down-regulated, and the loss of NCAM correlates with poor prognosis (8 -11). In contrast, in neuroblastoma and certain neuroendocrine tumors, cancer progression correlates with increased NCAM expression and extensive polysialylation (12)(13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%
“…In neuroblastoma expression of polySia-NCAM was highest in patients with advanced stage of disease and correlated with other prognostic markers, such as MYCN amplification (15). Furthermore serum levels of polySia-NCAM were shown to correlate with tumour content and were found to decrease during successful therapy (16). The key enzymes in the biosynthesis of polySia are the two closely related polysialyltransferases ST8SiaII and ST8SiaIV, formerly named STx and PST, respectively (17).…”
Section: Introductionmentioning
confidence: 99%
“…As an oncodevelopmental antigen, PSA is reexpressed during progression of several malignant human tumors, including small cell lung carcinoma, Wilms' tumor, neuroblastoma, and rhabdomyosarcoma (11,14,17). In these tumors, polysialylation of NCAM appears to increase the metastatic potential and has been correlated with tumor progression and a poor prognosis (7,8,14,16,17,48).…”
mentioning
confidence: 99%